<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39354784</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>02</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2219-0635</ISSN><JournalIssue CitedMedium="Internet"><Volume>91</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>04</Day></PubDate></JournalIssue><Title>The Onderstepoort journal of veterinary research</Title><ISOAbbreviation>Onderstepoort J Vet Res</ISOAbbreviation></Journal><ArticleTitle>Applied One Health: Nigeria National Veterinary Research Institute COVID-19 pandemic response.</ArticleTitle><Pagination><StartPage>e1</StartPage><EndPage>e6</EndPage><MedlinePgn>e1-e6</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2156</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.4102/ojvr.v91i2.2156</ELocationID><Abstract><AbstractText>The COVID-19 pandemic has caused the death of 7.1 million people worldwide as of 7 July 2024. In Nigeria, the first confirmed case was reported on 27 February 2020, subsequently followed by a nationwide spread of SARS-CoV-2 with morbidity and mortality reaching 267 173 and 3155, respectively, as of 7 July 2024. At the beginning of the pandemic, only a few public health laboratories in Nigeria had the capacity for SARS-CoV-2 molecular diagnosis. The National Veterinary Research Institute (NVRI), already experienced in influenza diagnosis, responded to the public health challenge for the diagnosis of COVID-19 samples from humans. The feat was possible through the collective utilisation of NVRI human and material resources, including biosafety facilities, equipment, reagents and consumables donated by international partners and collaborators. Within 6 months of the reported COVID-19 outbreak in Nigeria, over 33 000 samples were processed in NVRI facilities covering five states. Thereafter, many field and laboratory projects were jointly implemented between NVRI and collaborating sectors including the Nigerian Centre for Disease Control (NCDC) and the National Institute for Medical Research (NIMR), which brought together professionals in the health, veterinary, education and socio-sciences. In addition, One Health grants were secured to enhance surveillance for coronavirus and other zoonoses and build capacity in genomics. Bio-surveillance for coronaviruses and other emerging zoonotic pathogens at the human-animal interface was activated and continued with sample collection and analysis in the laboratory for coronaviruses, Lassa fever virus and Mpox. One Health approach has shown that inter-sectoral and multinational collaboration for diagnosis, research and development in animals, and the environment to better understand pathogen spillover events at the human-animal interface is an important global health priority and pandemic preparedness.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Meseko</LastName><ForeName>Clement A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Infectious and Transboundary Animal Diseases (ITADs), National Veterinary Research Institute, Vom Plateau State. cameseko@yahoo.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shittu</LastName><ForeName>Ismaila</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Asala</LastName><ForeName>Olayinka O</ForeName><Initials>OO</Initials></Author><Author ValidYN="Y"><LastName>Adedeji</LastName><ForeName>Adeyinka J</ForeName><Initials>AJ</Initials></Author><Author ValidYN="Y"><LastName>Laleye</LastName><ForeName>Tinuke A</ForeName><Initials>TA</Initials></Author><Author ValidYN="Y"><LastName>Agusi</LastName><ForeName>Ebere R</ForeName><Initials>ER</Initials></Author><Author ValidYN="Y"><LastName>Gado</LastName><ForeName>Dorcas A</ForeName><Initials>DA</Initials></Author><Author ValidYN="Y"><LastName>Olawuyi</LastName><ForeName>Kayode A</ForeName><Initials>KA</Initials></Author><Author ValidYN="Y"><LastName>Mkpuma</LastName><ForeName>Nicodemus</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Chinonyerem</LastName><ForeName>Chinyere</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Inuwa</LastName><ForeName>Bitrus</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Chima</LastName><ForeName>Nneka</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Akintola</LastName><ForeName>Ruth</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Nyango</LastName><ForeName>Patrick</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Luka</LastName><ForeName>Hellen</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Bakam</LastName><ForeName>Judith</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Atai</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Kabantiyok</LastName><ForeName>Dennis</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Samson</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Daniel</LastName><ForeName>ThankGod</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Oyetunde</LastName><ForeName>Joshua</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Owolodun</LastName><ForeName>Olajide A</ForeName><Initials>OA</Initials></Author><Author ValidYN="Y"><LastName>Lazarus</LastName><ForeName>David D</ForeName><Initials>DD</Initials></Author><Author ValidYN="Y"><LastName>Obishakin</LastName><ForeName>Emmanuel T</ForeName><Initials>ET</Initials></Author><Author ValidYN="Y"><LastName>Luka</LastName><ForeName>Pam D</ForeName><Initials>PD</Initials></Author><Author ValidYN="Y"><LastName>Audu</LastName><ForeName>Benshak J</ForeName><Initials>BJ</Initials></Author><Author ValidYN="Y"><LastName>Makama</LastName><ForeName>Sunday</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Ularamu</LastName><ForeName>Hussaini G</ForeName><Initials>HG</Initials></Author><Author ValidYN="Y"><LastName>Wungak</LastName><ForeName>Yiltawe S</ForeName><Initials>YS</Initials></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>James S</ForeName><Initials>JS</Initials></Author><Author ValidYN="Y"><LastName>Ocholi</LastName><ForeName>Reuben A</ForeName><Initials>RA</Initials></Author><Author ValidYN="Y"><LastName>Muhammad</LastName><ForeName>Maryam</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>South Africa</Country><MedlineTA>Onderstepoort J Vet Res</MedlineTA><NlmUniqueID>0401107</NlmUniqueID><ISSNLinking>0030-2465</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000662" MajorTopicYN="N">veterinary</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009549" MajorTopicYN="N" Type="Geographic">Nigeria</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000074823" MajorTopicYN="Y">One Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011634" MajorTopicYN="N">Public Health</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 pandemic</Keyword><Keyword MajorTopicYN="N">NVRI</Keyword><Keyword MajorTopicYN="N">One Health</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">diagnosis</Keyword></KeywordList><CoiStatement>The authors declare that they have no financial or personal relationships that may have inappropriately influenced them in writing this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>7</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>7</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>2</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39354784</ArticleId><ArticleId IdType="pmc">PMC11447676</ArticleId><ArticleId IdType="doi">10.4102/ojvr.v91i2.2156</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Agusi, E.R., Allendorf, V., Eze, E.A., Asala, O., Shittu, I., Dietze, K. et al. ., 2022, ‘SARS-CoV-2 at the human-animal interface: Implication for global public health from an African Perspective’, Viruses 14(11), 2473. 10.3390/v14112473</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14112473</ArticleId><ArticleId IdType="pmc">PMC9696393</ArticleId><ArticleId IdType="pubmed">36366571</ArticleId></ArticleIdList></Reference><Reference><Citation>Agusi, E.R., Schön, J., Allendorf, V., Eze, E.A., Asala, O., Shittu, I. et al. ., 2024, ‘SARS-CoV and SARS-CoV-2 cross-reactive antibodies in domestic animals and wildlife in Nigeria suggest circulation of sarbecoviruses’, One Health 18, 100709. 10.1016/j.onehlt.2024.100709</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.onehlt.2024.100709</ArticleId><ArticleId IdType="pmc">PMC10963646</ArticleId><ArticleId IdType="pubmed">38533194</ArticleId></ArticleIdList></Reference><Reference><Citation>Falang, K.D., Poyi, C.O., Ajima, U., Bukar, B.B., Amagon, K.I., Damen, J.G. et al. ., 2020, ‘Combinatorial evaluation of antiviral activity of some Nigerian medicinal plants on SARS-CoV-2’, Journal of Complementary and Alternative Medical Research 12(1), 38–50. 10.9734/jocamr/2020/v12i130199</Citation><ArticleIdList><ArticleId IdType="doi">10.9734/jocamr/2020/v12i130199</ArticleId></ArticleIdList></Reference><Reference><Citation>Forcados, G.E., Muhammad, A., Oladipo, O.O., Makama, S. &amp; Meseko, C.A., 2021, ‘Metabolic implications of oxidative stress and inflammatory process in SARS-CoV-2 pathogenesis: Therapeutic potential of natural antioxidants’, Frontiers in Cellular and Infection Microbiology 11. 10.3389/fcimb.2021.654813</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.654813</ArticleId><ArticleId IdType="pmc">PMC8188981</ArticleId><ArticleId IdType="pubmed">34123871</ArticleId></ArticleIdList></Reference><Reference><Citation>Gard, L., Fliss, M.A., Bosma, F., Ter Veen, D. &amp; Niesters, H.G.M., 2022, ‘Validation and verification of the GeneFinder™ COVID-19 Plus RealAmp kit on the ELITe InGenius® instrument’, Journal of Virological Methods 300, 114378. 10.1016/j.jviromet.2021.114378</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2021.114378</ArticleId><ArticleId IdType="pmc">PMC8611827</ArticleId><ArticleId IdType="pubmed">34838535</ArticleId></ArticleIdList></Reference><Reference><Citation>Hailemariam, B.W., Zealiyas, K., Gutema, G., Gebremicael, G., Adane, S., Tadele, S. et al. ., 2022, ‘Performances of four nucleic acid amplification tests for the identification of SARS-CoV-2 in Ethiopia’, Scientific Reports 12, 20282. 10.1038/s41598-022-24411-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-24411-2</ArticleId><ArticleId IdType="pmc">PMC9700788</ArticleId><ArticleId IdType="pubmed">36434013</ArticleId></ArticleIdList></Reference><Reference><Citation>Itodo, U.F., 2023, ‘A History of Exploitation of the Colonised in Northern Nigeria During the Influenza Pandemic of 1918–1919’, African Historical Review 54(2), 13–36. 10.1080/17532523.2024.2314401</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17532523.2024.2314401</ArticleId></ArticleIdList></Reference><Reference><Citation>Joannis, T.M., Meseko, C.A., Oladokun, A.T., Ularamu, H.G., Egbuji, A.N., Solomon, P. et al. ., 2008, ‘Serologic and virologic surveillance of avian influenza in Nigeria, 2006-7’, Eurosurveillance 13(42), 19007. 10.2807/ese.13.42.19007-en</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/ese.13.42.19007-en</ArticleId><ArticleId IdType="pubmed">18926110</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabantiyok, D., Ninyio, N., Shittu, I., Meseko, C., Emeto, T.I. &amp; Adegboye, O.A., 2022, ‘Human respiratory infections in Nigeria: Influenza and the emergence of SARS-CoV-2 pandemic’, Vaccines 10(9), 1551. 10.3390/vaccines10091551</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10091551</ArticleId><ArticleId IdType="pmc">PMC9506385</ArticleId><ArticleId IdType="pubmed">36146628</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu, Y., Li, L., Ren, S., Liu, X., Zhang, L., Li, W. et al. ., 2020, ‘Comparison of the diagnostic efficacy between two PCR test kits for SARS-CoV-2 nucleic acid detection’, Journal of Clinical Laboratory Analysis 34(10), e23554. 10.1002/jcla.23554</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcla.23554</ArticleId><ArticleId IdType="pmc">PMC7536918</ArticleId><ArticleId IdType="pubmed">32977349</ArticleId></ArticleIdList></Reference><Reference><Citation>Meseko, C.A., Heidari, A., Odaibo, G.N. &amp; Olaleye, D.O., 2019, ‘Complete genome sequencing of H1N1pdm09 swine influenza isolates from Nigeria reveals likely reverse zoonotic transmission at the human-animal interface in intensive piggery’, Infection Ecology &amp; Epidemiology 9(1). 10.1080/20008686.2019.1696632</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/20008686.2019.1696632</ArticleId><ArticleId IdType="pmc">PMC6896411</ArticleId><ArticleId IdType="pubmed">31839904</ArticleId></ArticleIdList></Reference><Reference><Citation>Meseko, C., Adedeji, A., Shittu, I., Obishakin, E., Nanven, M., Suleiman, L. et al. ., 2023, ‘Orthopoxvirus infections in rodents, Nigeria, 2018–2019’, Emerging Infectious Diseases 29(2), 433–434. 10.3201/eid2902.221411</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2902.221411</ArticleId><ArticleId IdType="pmc">PMC9881785</ArticleId><ArticleId IdType="pubmed">36692495</ArticleId></ArticleIdList></Reference><Reference><Citation>Meseko, C., Shittu, I. &amp; Adedeji, A., 2020, ‘The bush meat trade thrives in Nigeria despite anxiety over coronavirus’, Transactions of The Royal Society of Tropical Medicine and Hygiene 114(9), 639–641. 10.1093/trstmh/traa060</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/trstmh/traa060</ArticleId><ArticleId IdType="pmc">PMC7454903</ArticleId><ArticleId IdType="pubmed">32730611</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills, M.G., Bruce, E., Huang, M-L., Crothers, J.W., Hyrien, O., Oura, C.A.L. et al. ., 2022, ‘An international, interlaboratory ring trial confirms the feasibility of an extraction-less “direct” RT-qPCR method for reliable detection of SARS-CoV-2 RNA in clinical samples’, PLoS One 17(1), e0261853. 10.1371/journal.pone.0261853</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0261853</ArticleId><ArticleId IdType="pmc">PMC8758094</ArticleId><ArticleId IdType="pubmed">35025926</ArticleId></ArticleIdList></Reference><Reference><Citation>Phelan, A.L., Katz, R. &amp; Gostin, L.O., ‘The novel coronavirus originating in Wuhan, China: Challenges for global health governance’, Journal of American Medical Association 323(8), 709–710. 10.1001/jama.2020.1097</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.1097</ArticleId><ArticleId IdType="pubmed">31999307</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Kasteren, P.B., Van Der Veer, B., Van Den Brink, S., Wijsman, L., De Jonge, J, Van Den Brandt, A. et al. ., 2020, ‘Comparison of seven commercial RT-PCR diagnostic kits for COVID-19’, Journal of Clinical Virology 128, 104412. 10.1016/j.jcv.2020.104412</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2020.104412</ArticleId><ArticleId IdType="pmc">PMC7206434</ArticleId><ArticleId IdType="pubmed">32416600</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, B., Hu, M., Ren, Y., Xu, X., Wang, Z., Lyu, X. et al. ., 2020, ‘Evaluation of seven commercial SARS-CoV-2 RNA detection kits based on real-time polymerase chain reaction (PCR) in China’, Clinical Chemistry and Laboratory Medicine (CCLM) 58(9), e149–e153. 10.1515/cclm-2020-0271</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2020-0271</ArticleId><ArticleId IdType="pubmed">32651975</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, M., Chen, D., Wu, W., Tang, H., Kan, L., Zong, Z. et al. ., 2021, ‘Analytical performance evaluation of five RT-PCR kits for severe acute respiratory syndrome coronavirus-2’, Journal of Clinical Laboratory Analysis 35(1), e23643. 10.1002/jcla.23643</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcla.23643</ArticleId><ArticleId IdType="pmc">PMC7645906</ArticleId><ArticleId IdType="pubmed">33107116</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>